Biotechnology

AstraZeneca Sold Its Stake In Moderna For More Than $1 Billion: Report

World News | Reuters | Monday March 1, 2021

AstraZeneca Plc has sold its 7.7% stake in Moderna Inc for more than $1 billion after the U.S. biotechnology company's shares soared on the back of its coronavirus vaccine breakthrough, The Times reported.

Dharmendra Pradhan Seeks Centre Of Excellence On Marine Biotechnology In Odisha

Education | Reported by PTI | Wednesday February 17, 2021

Union minister Dharmendra Pradhan has sought the personal intervention of Union Science and Technology Minister Harsh Vardhan in setting up of a Centre of Excellence (CoE) on Marine Biotechnology at Institute of Life Sciences in Odisha.

Pfizer Vaccine Can Neutralise UK, South Africa Virus Variants: Study

World News | Press Trust of India | Tuesday February 9, 2021

The COVID-19 vaccine co-developed by the American pharmaceutical giant Pfizer and the German biotechnology company BioNTech can neutralise variants of the novel coronavirus that were first reported in the UK and South Africa, a new study suggests.

Moderna Says Its Vaccine Effective Against UK, South Africa Mutant Strain

World News | Agence France-Presse | Monday January 25, 2021

US biotechnology firm Moderna on Monday said lab studies showed its Covid-19 vaccine would remain protective against variants of the coronavirus first identified in the United Kingdom and South Africa.

Zydus Cadila Gets Nod For Phase 3 Trials Of Its Covid Vaccine Candidate

India News | Press Trust of India | Sunday January 3, 2021

The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of Biotechnology said on Sunday.

Moderna COVID-19 Vaccine Shows 94.1% Efficacy In Trial: Study

World News | Press Trust of India | Thursday December 31, 2020

Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna's COVID-19 vaccine have revealed 94.1 per cent efficacy of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study.

Over 100 Experts From Friendly Nations Trained For Clinical Trials Of Indian Covid Vaccine: Official

India News | Press Trust of India | Thursday December 17, 2020

Over 100 experts from friendly neighbouring nations have so far been trained to strengthen capacities in their countries for facilitating phase-3 clinical trials of Indian COVID-19 vaccine, a senior official of the department of biotechnology said on Wednesday.

COVID-19 Vaccine Safety, Efficacy Not A Concern: Biocon Chief Kiran Mazumdar-Shaw

India News | Press Trust of India | Thursday December 10, 2020

Biotechnology industry veteran Kiran Mazumdar-Shaw said on Wednesday that she will get the COVID-19 vaccine though its durability is not fully known as of now.

What's Wrong In Naming Kerala Institute After RSS Leader, Asks Union Minister

India News | Press Trust of India | Sunday December 6, 2020

With a controversy erupting in Kerala over the Centre's decision to name the second campus of Rajiv Gandhi Centre for Biotechnology after RSS ideologue MS Golwalkar, Union minister V Muraleedharan on Sunday backed the move and said there was nothing wrong in naming it after a "patriot".

Don't Name Institute After RSS Leader MS Golwalkar: Kerala Chief Minister To Centre

India News | Reported by Sneha Mary Koshy, Edited by Debanish Achom | Sunday December 6, 2020

Kerala Chief Minister Pinarayi Vijayan has written to Science and Technology Minister Harsh Vardhan, asking him not to rename Rajiv Gandhi Centre for Biotechnology (RGCB) in Thiruvananthapuram under Rashtriya Swayamsevak Sangh ideologue MS Golwalkar.

Biocon To Buy 26% Stake In Hinduja Renewables Two

Business | Edited by Peter Noronha | Tuesday November 24, 2020

"The cost of the acquisition is Rs 5,91,61,730 for the acquisition of 26 per cent stake on a fully diluted basis in one or more tranches," the Bangalore-based Biocon said in a BSE filing.

Finance Minister Announces Rs 900 Crore Grant For COVID-19 Vaccine Research

India News | Press Trust of India | Thursday November 12, 2020

Finance Minister Nirmala Sitharman today announced a Rs 900 crore grant to the Department of Biotechnology for COVID-19 vaccine research.

Indian-American Gets Utah Governor's Lifetime Achievement Medal

Indians Abroad | Press Trust of India | Thursday October 29, 2020

Eminent Indian-American entrepreneur Dr Dinesh C Patel has been honored with Utah Governor's Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals.

5-Year-Old Girl, Being Treated In French Gene Therapy Trial, Dies In US

World News | Agence France-Presse | Thursday October 15, 2020

A five-year-old girl with a rare neurodegenerative disease died in the US while taking part in a gene therapy trial run by French biotechnology company Lysogene, the firm said Thursday.

India Launches Program To Strengthen Clinical Trial Research Of Vaccines In Neighbouring Nations

India News | Press Trust of India | Wednesday September 23, 2020

Amid the COVID-19 pandemic, India has started a "science diplomacy" initiative by launching a programme to strengthen the capacity of clinical trial research of vaccines in neighbouring countries, the Department of Biotechnology said today.